Human medicines European public assessment report (EPAR): Filspari, sparsentan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Filspari, sparsentan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised

Committee for Medicinal Products for Human Use (CHMP): 08-11 December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025 to 11 December 2025

Committee for Medicinal Products for Human Use (CHMP): 08-11 December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025 to 11 December 2025

EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 November 2025, 09:00 (CET) to 25 November 2025, 16:00 (CET)

EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 November 2025, 09:00 (CET) to 25 November 2025, 16:00 (CET)

Quarterly System Demo - Q4 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 December 2025, 09:30 (CET) to 16 December 2025, 12:35 (CET)

Quarterly System Demo - Q4 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 December 2025, 09:30 (CET) to 16 December 2025, 12:35 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness